PTGS2 is an inflammation-inducing enzyme that is mainly involved in the inflammatory response.[32] Studies have shown that inhibition of PTGS2 can reduce inflammation through the NF-κB signaling pathway, thereby potentially treating asthma.[33] BCL2 is a key factor in the mitochondrial apoptosis pathway. This evidence concerns the gene BCL2 and asthma.